Medicare Enrolled
Dr. Aurelio Cervera, MD
Cardiovascular Disease · Lubbock, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cervera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cervera? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cervera
Dr. Aurelio Cervera is a cardiovascular disease in Lubbock, TX, with 18 years in practice. Based on federal Medicare data, Dr. Cervera performed 10,846 Medicare services across 5,616 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cervera received a total of $13,476 from 32 pharmaceutical and/or device companies across 415 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cervera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 3% volume in TX$ $13,476 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,846
Medicare services
Top 3% in TX for cardiovascular disease
5,616
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~603 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days | 2,099 | $15 | $61 |
| Electrocardiogram (EKG), 12-lead | 1,824 | $10 | $41 |
| Office visit, established patient (30-39 min) | 1,578 | $89 | $259 |
| Remote pacemaker monitoring, 90 days | 1,551 | $20 | $84 |
| Chronic care management, first 20 min/month | 655 | $47 | $62 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 550 | $24 | $166 |
| Office visit, established patient, complex (40-54 min) | 386 | $122 | $349 |
| Office visit, established patient (20-29 min) | 296 | $61 | $176 |
| Programming of dual lead pacemaker system | 253 | $55 | $141 |
| Ultrasound of heart with probe in esophagus, with report | 156 | $80 | $301 |
| Ultrasound of heart blood flow, valves and chambers | 156 | $13 | $46 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 156 | $2 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 134 | $9 | $123 |
| New patient office visit, complex (60-74 min) | 128 | $154 | $500 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 69 | $701 | $2,811 |
| Echocardiogram, transthoracic | 66 | $126 | $539 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 65 | $11 | $39 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 60 | $229 | $1,066 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 56 | $18 | $66 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 54 | $25 | $100 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 52 | $19 | $65 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 52 | $226 | $1,067 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 50 | $632 | $1,743 |
| Programming of multiple lead implantable defibrillator system | 42 | $80 | $218 |
| Programming of single lead pacemaker system | 38 | $48 | $120 |
| New patient office visit (45-59 min) | 34 | $119 | $398 |
| External shock to heart to regulate heart beat | 33 | $77 | $495 |
| Hospital follow-up visit, moderate complexity | 33 | $61 | $177 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 32 | $613 | $2,094 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 31 | $382 | $1,300 |
| Programming of dual lead implantable defibrillator system | 26 | $70 | $198 |
| Removal and replacement of dual lead permanent pacemaker | 25 | $258 | $877 |
| Insertion of implantable defibrillator system | 23 | $660 | $2,288 |
| Repair of left upper heart chamber with implant with review by radiologist | 21 | $582 | $1,862 |
| Initial hospital admission, high complexity | 21 | $133 | $496 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 16 | $346 | $1,177 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 13 | $54 | $183 |
| Programming of single lead implantable defibrillator system | 12 | $62 | $152 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
48.5% high complexity
1.6% medium
49.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,476
Total received (2018-2024)
Avg $1,925/year across 7 years
Top 25% in TX for cardiovascular disease
32
Companies
415
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,462 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,505
2023$2,644
2022$2,530
2021$1,482
2020$971
2019$1,167
2018$2,176
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$5,443
Medtronic, Inc.
$2,600
Medtronic Vascular, Inc.
$1,411
Janssen Pharmaceuticals, Inc
$655
BOSTON SCIENTIFIC CORPORATION
$585
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$570
Boston Scientific Corporation
$450
SANOFI-AVENTIS U.S. LLC
$322
PFIZER INC.
$206
Amgen Inc.
$174
E.R. Squibb & Sons, L.L.C.
$155
Novartis Pharmaceuticals Corporation
$143
CVRx, Inc.
$131
AstraZeneca Pharmaceuticals LP
$127
Endologix LLC
$86
CARDIVA MEDICAL, INC.
$63
Innovation Technologies Inc
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Esperion Therapeutics, Inc.
$30
Daiichi Sankyo Inc.
$27
CORDIS US CORP.
$26
Actelion Pharmaceuticals US, Inc.
$25
Philips Electronics North America Corporation
$22
Alnylam Pharmaceuticals Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
Braemar Manufacturing, LLC
$18
Cook Medical LLC
$16
Canon Medical Systems USA, Inc.
$14
Amarin Pharma Inc.
$13
Merck Sharp & Dohme Corporation
$12
BIOTRONIK INC.
$10
Bardy Diagnostics, Inc.
$8
Top 3 companies account for 70.2% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · ABRE · ABSOLUTE PRO · ADVISOR · AGILIS HISPRO · AMPLATZER · AMPLATZER Occluders · ANGIOJET · ASSURITY · AVEIR · AZURE XT DR MRI SURESCAN · Absolute Pro vascular stent system · Accent Pacemaker · Advisa · Alto Abdominal Stent Graft System · Arctic Front · Assurity Pacemaker · BRILINTA · BRITE TIP RADIANZ · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · COMET · Cardiac Monitoring Suite · Cardiva VASCADE MVP VVCS 6-12F · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · DRAGONFLY OPSTAR · ELIQUIS · ENDOTAK · ENSITE · ENSITE PRECISION · ENTRESTO · EVOLUTION · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · GALLANT · GENERAL STENTS · GENERAL BRADY · GENERAL DEVICE(S) · GENERAL TACHY · GENERAL THERAPIES · GRAFTMASTER · GUIDEZILLA · GraftMaster coronary stent system · HAWKONE · HERCULINK ELITE · HI-TORQUE BALANCE · HI-TORQUE PILOT · HawkOne · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hi-Torque Balance Guide Wires · ILAB · IN.PACT Admiral · INDEFLATOR · INJECTAFER · INOGEN · IRRISEPT · JARDIANCE · JETI PERIPHERAL CATHETER · JOT DX · Kerendia · LATITUDE · LEQVIO · LifeVest · MERLIN@HOME · MOMENTUM · MULTAQ · Merlin Connectivity and Remote · Micra · Multi-Link Mini Vision coronary stent system · Multi-Link Ultra coronary stent system · NC TREK · NC TREK NEO · NC TREK coronary catheters · NEXLETOL · OMNILINK ELITE · ONPATTRO · OPSUMIT · OPTIS · PERCEPTA QUAD CRT-P MRI SURESCAN · PERCLOSE PROGLIDE · PERCLOSE PROSTYLE · PRESSUREWIRE · PULSESELECT · Perclose ProGlide suture mediated closure system · ROTABLATOR · Repatha · SENSOR ENABLED · SUPERA · SYNERGY · Supera peripheral stent system · TACTICATH · TACTICATH ABLATION CATHETER · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TURBOHAWK · TactiCath Quartz CFA Catheter · VANTAGEVIEW · VERQUVO · VIATRAC · VYNDAQEL · Vascepa · WATCHMAN · WOLVERINE · WOLVERINE CORONARY CUTTING BALLOON · Wolverine Coronary Cutting Balloon · XACT · XARELTO · XIENCE ALPINE · XIENCE SIERRA · XIENCE SKYPOINT · Xience Alpine coronary stent system · Xience Sierra Coronary Stent · iLab
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $124 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
19
Per 100K population
6.0
County median income
$63,367
Nearest hospital
COVENANT MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cervera is a electrophysiology & remote specialist, with above-average Medicare volume (top 3% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cervera experienced with remote pacemaker/defibrillator monitoring, 90 days?
Based on Medicare claims data, Dr. Cervera performed 2,099 remote pacemaker/defibrillator monitoring, 90 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cervera receive payments from pharmaceutical companies?
Yes. Dr. Cervera received a total of $13,476 from 32 companies across 415 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cervera's costs compare to other cardiovascular diseases in Lubbock?
Dr. Cervera's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cervera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Lubbock
Browse cardiovascular diseases in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology